CODX Co-Diagnostics Corp: Multiplikator forward rega marang pendapatan

Co-Diagnostics Corp - logo grafis emiten CODX

The stability of Co-Diagnostics, Inc. (CODX) is underpinned by the humanitarian status of medicine and the absence of geopolitical sanctions. Capitalization is based on the sale of PCR systems and the licensing of molecular developments. Demand for diagnostics is independent of economic cycles, exhibiting a winter peak. The forward P/S ratio reflects market expectations, where the value of 4.00 characterizes this valuation level relative to expected sales.

codiagnostics.com - Kapitalisasi marang prakiraan pendapatan CODX (periode 04.07.2022 - 13.11.2026)

Rincian metrik lan analitis perusahaan CoDx (CODX)

- rega pasar lan target rega analis:
Bagan rega Co-Diagnostics|CODX - Rata-rata rega prakiraan
- data kapitalisasi saham perusahaan:
Biji pasar CoDx|CODX - Nilai Perusahaan Nalika Diakuisisi Penuh
- rincian valuasi buku bisnis:
Nilai Buku saben Saham Co-Diagnostics|CODX - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku codiagnostics.com|CODX - Gunggung Aset Perusahaan
- rincian utang lan likuiditas:
Total Utang marang Modal Co-Diagnostics, Inc.|CODX - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Co-Diagnostics, Inc.|CODX - Tanggungan utang total perusahaan|Rasio utang marang kapitalisasi buku CoDx|CODX - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Co-Diagnostics|Likuiditas cepet codiagnostics.com
- rincian asil keuangan lan kelipatan valuasi:
CODX - Asil keuangan resik|Bathi mangsa ngarep Co-Diagnostics, Inc.|CODX - Rasio rega pasar marang bathi resik|Pangali Forward P/E Co-Diagnostics Corp|CODX - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA CoDx|CODX - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Co-Diagnostics|CODX - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan codiagnostics.com|CODX - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Co-Diagnostics, Inc.
- indikator dodolan lan pendapatan:
CODX - Pendapatan reged perusahaan|Prakiraan pendapatan perusahaan Co-Diagnostics|CODX - Rasio kapitalisasi marang pendapatan|Multiplikator Forward P/S CoDx
Analisis dhasar perusahaan:CODX (Co-Diagnostics)
Sampel barang CoDx

DNA sequencing automation at Co-Diagnostics, Inc. (CODX) creates a foundation for revenue scaling, yet the forward P/S ratio allows for an assessment of how much the market is willing to pay a premium for this technological potential. Analyzing this metric compares market capitalization with expected sales volume to identify whether the asset is overheated or possesses hidden growth potential, which determines the fundamental stability of the investment amid inflationary pressures.

Analisis pesaing Co-Diagnostics, Inc.

Rasio rega marang prakiraan pendapatan Agilent A|Quest Diagnostics Inc. (DGX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ILMN: Multiplikator forward rega marang pendapatan|Prakiraan rega marang pendapatan Exact Sciences Inc. (EXAS)|RVTY: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan BIO|NNNN (Anbio) - Multiplikator Forward P/S|Sotera Health Corp (SHC) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S QDEL|Multiplikator Forward P/S OPKO Health Corp. (OPK)|Multiplikator Forward P/S CDNA (CareDx, Inc)|Prakiraan rega marang pendapatan maravai.com|FLGT - Rasio rega marang prakiraan pendapatan|LAB (Standard BioTools Inc) - Kapitalisasi marang prakiraan pendapatan|Cytek Bio (CTKB) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep OraSure Corp (OSUR)|Rasio rega marang prakiraan pendapatan Exagen Inc|mdxhealth.com (MDXH) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan LUCD (Lucid Diagnostics)|Rasio rega marang pendapatan sing dikarepake PRE|Multiplikator Forward P/S IMDX (Insight Molecular Diagnostics Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Trinity Biotech PLC (TRIB)|ProPhase Labs, Inc. - Multiplikator Forward P/S|ainos.com (AIMD) - Multiplikator forward rega marang pendapatan|HeartSciences (HSCS) - Rasio rega marang prakiraan pendapatan|BMRA - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan CDIO|ONCO: Rega forward marang dodolan|Multiplikator Forward P/S VRAX|Rasio kapitalisasi marang dodolan sing dikarepake bluejaydx.com|Rasio rega marang prakiraan pendapatan Aspira Women's Health Inc. AWH|AXDX: Kapitalisasi marang prakiraan pendapatan|centogene.com - Multiplikator Forward P/S|Enzo Biochem, Inc. (ENZ) - Multiplikator forward rega marang pendapatan|FRES (fresh2.co) - Multiplikator forward rega marang pendapatan|GENE - Rasio kapitalisasi marang dodolan sing dikarepake|ME (23andMe) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Psychemedics Corp. (PMD)